Earnings ·
Definitive Healthcare reports Q3 revenue of $54.7M as Advent International submits non-binding acquisition proposal
DHDefinitive Healthcare Corp.
Definitive Healthcare reported third-quarter revenue of $54.7 million, a 9% decline from the prior year period, while narrowing its net loss to $5.4 million from $17.8 million in Q3 2025. Adjusted EBITDA came in at $15.7 million against $18.9 million previously. Concurrently, the company disclosed that Advent International submitted a non-binding indication of interest to acquire all outstanding shares of Class A common stock and LLC interests not already owned by Advent or founder Jason Krantz. Due to this potential transaction, the company will not provide financial guidance or host an earnings conference call. Definitive Healthcare operates in the healthcare market data and analytics industry.